Johnson Matthey (LON:JMAT)‘s stock had its “buy” rating reaffirmed by Liberum Capital in a research note issued on Thursday, March 28th, ThisIsMoney.Co.Uk reports.
JMAT has been the topic of a number of other reports. UBS Group restated a “sell” rating on shares of Johnson Matthey in a research note on Thursday, March 28th. Barclays boosted their price objective on Johnson Matthey from GBX 4,060 ($53.05) to GBX 4,080 ($53.31) and gave the company an “overweight” rating in a research note on Friday, December 7th. HSBC restated a “buy” rating on shares of Johnson Matthey in a research note on Tuesday, January 8th. Credit Suisse Group restated an “outperform” rating on shares of Johnson Matthey in a research note on Wednesday, December 12th. Finally, Deutsche Bank reiterated a “buy” rating on shares of Johnson Matthey in a research report on Wednesday, March 27th. One research analyst has rated the stock with a sell rating and nine have issued a buy rating to the stock. Johnson Matthey presently has an average rating of “Buy” and a consensus target price of GBX 3,797.14 ($49.62).
Johnson Matthey stock traded down GBX 18 ($0.24) during midday trading on Thursday, reaching GBX 3,436 ($44.90). The stock had a trading volume of 391,663 shares, compared to its average volume of 691,012. Johnson Matthey has a 12 month low of GBX 2,574 ($33.63) and a 12 month high of GBX 3,873 ($50.61). The stock has a market capitalization of $6.60 billion and a P/E ratio of 19.85. The company has a debt-to-equity ratio of 46.19, a quick ratio of 1.13 and a current ratio of 1.95.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.